Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Bagg

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Haematologica|December 24, 2025
Isolated <i>KRAS</i> and <i>NRAS</i> mutations in adults with monocytosis and/or cytopenia(s)Sa A Wang, Chi Young Ok, Harrison K Tsai, et al.
Blood|November 8, 2019
Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversionYan Xiu, Qianze Dong, Lin Fu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2021
Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.
Blood|March 15, 2014
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasmsSa A Wang, Robert P Hasserjian, Patricia S Fox, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Leukemia Research|November 4, 2022
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotypeMaximiliano Ramia de Cap, Leo P Wu, German A Pihan, et al.
Blood Advances|February 14, 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registrySheila K Pierson, Joshua D Brandstadter, Drew A Torigian, et al.
Blood|June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaGerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Cell|June 2, 2018
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid LeukemiaMiriam Y Kim, Kyung-Rok Yu, Saad S Kenderian, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Haematologica|December 24, 2025
Isolated <i>KRAS</i> and <i>NRAS</i> mutations in adults with monocytosis and/or cytopenia(s)Sa A Wang, Chi Young Ok, Harrison K Tsai, et al.
Blood|November 8, 2019
Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversionYan Xiu, Qianze Dong, Lin Fu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2021
Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.
Blood|March 15, 2014
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasmsSa A Wang, Robert P Hasserjian, Patricia S Fox, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Leukemia Research|November 4, 2022
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotypeMaximiliano Ramia de Cap, Leo P Wu, German A Pihan, et al.
Blood Advances|February 14, 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registrySheila K Pierson, Joshua D Brandstadter, Drew A Torigian, et al.
Blood|June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaGerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Cell|June 2, 2018
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid LeukemiaMiriam Y Kim, Kyung-Rok Yu, Saad S Kenderian, et al.
Pageof 22